Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| FibroGen Announces Initiation of Phase 2b Studies of FG-4592, an Oral HIF ... - Lifescience-online |
 |
 |
|
Lifescience-online advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis. The advancement decision resulted in a payment ... FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of |
